Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  West Pharmaceutical Services Inc.    WST

Delayed Quote. Delayed  - 07/27 09:08:48 pm
78.46 USD   +0.51%
07/23 WEST PHARMACEUT : Gw&k Investment Management Lowers stake in West Ph..
07/23 WEST PHARMACEUT : Shares of West Pharmaceutical Services Sees Large ..
07/18 WEST PHARMACEUT : ex-dividend day
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Sales1 3681 4211 4001 5041 6301 750
Operating income (EBITDA)248273280331381425
Operating profit (EBIT)162183190226274316
Pre-Tax Profit (EBT)------
Net income11212795,6161197236
P/E ratio31,230,446,339,229,625,2
EPS ( $ )1,571,751,301,992,633,10
Dividend per Share ( $ )0,390,410,460,490,530,58
Yield0,79%0,77%0,76%0,63%0,68%0,74%
Reference price ( $ )49.0653.2460.2278.0678.0678.06
Announcement Date02/20/2014
12:00pm
02/19/2015
12:00pm
02/18/2016
12:00pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Debt---23,013,028,0
Finance------
Operating income (EBITDA)248273280331381425
Leverage
(Debt/EBITDA)
---0,07x0,03x0,07x
Capital Expenditure--132162158155
Book Value Per Share (BVPS)--14,2 $15,3 $16,9 $19,3 $
Cash Flow per Share3,09 $2,51 $2,88 $3,04 $3,91 $4,42 $
Announcement Date02/20/2014
12:00pm
02/19/2015
12:00pm
02/18/2016
12:00pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 5 704 M$ -
Entreprise Value (EV) 5 727 M$ 5 717 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 39,2x 29,6x
Capitalization / Revenue 3,79x 3,50x
EV / Revenue 3,81x 3,51x
EV / EBITDA 17,3x 15,0x
Yield (DPS / Price) 0,63% 0,68%
Price to book (Price / BVPS) 5,10x 4,62x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 15,1% 16,8%
operating Leverage (Delta EBIT / Delta Sales) 2,58x 2,49x
Net Margin (Net Profit / Revenue) 10,7% 12,1%
ROA (Net Profit / Asset) 8,30% 10,6%
ROE (Net Profit / Equities) 13,9% 15,6%
Rate of Dividend 24,6% 20,1%
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   10,8% 9,71%
Cash Flow / Sales 14,8% 17,5%
Capital Intensity (Assets / Sales) 1,29x 1,14x
Financial Leverage (Net Debt / EBITDA) 0,07x 0,03x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend